Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 1002-1008

  Bart, Bradley A ^a,b   Shaw, Linda K ^a   McCants Jr , Charles B ^a   Fortin, Donald F ^a   Lee, Kerry L ^a   Califf, Robert M ^a   O'Connor, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0030819472     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00235-0     Document Type: Article

References (31)

1. Anversa P, Kajstura J, Reiss K, et al. Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia. Ann N Y Acad Sci 1995;752:47-64.
2. Bourassa MG, Gurne O, Bangdiwala SI, et al., the Studies Of Left Ventricular Dysfunction (SOLVD) Investigators. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22 Suppl A:14A-9A.
3. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68: 785-95.
4. Gersh BJ, Kronmal RA, Schaff HV, et al. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the Coronary Artery Surgery Study (CASS) Registry. N Engl J Med 1985;313:217-24.
5. O'Connor CM, Puma JA, Gardner LH, Califf RM, Jones RH. A 25-year experience in patients with coronary artery disease and chronic heart failure: outcomes with medical therapy and bypass surgery [abstract]. J Am Coll Cardiol 1995;27 Suppl A:142A.
6. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
7. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
8. Singh SN, Fisher SG, Singh BN, Massie BM, Fletcher RD. Ischémic vs nonischemic cardiomyopathy: clinical outcome and response to amiodarone [abstract]. J Am Coll Cardiol 1996;27 Suppl A:203A.
9. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73.
10. Gheorghiade M, Young JB, Uretsky BF, Packer M. The effects of digoxin withdrawal in patients with stable heart failure due to coronary artery disease compared to primary cardiomyopathy: insights from the PROVED and RADIANCE studies. Circulation 1995;92 Suppl I:I-142.
11. Yusuf S, Garg R, Smith T, et al. Which heart failure patients benefit the most from long term digoxin therapy? Circulation 1996;94 Suppl I:I-23.
12. Rosati RA, McNeer JF, Starmer CF, et al. A new information system for medical practice. Arch Intern Med 1975;135:1017-24.
13. Harris PJ, Harrell FE Jr., Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation 1979;60:1259-69.
14. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.
15. Califf RM, Harrell FE Jr., Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA 1989;261:2077-86.
16. Patterson JE, Bilgrad R. The National Death Index experience. In: Record Linkage Techniques - 1985: Proceedings of the Workshop on Exact Matching Methodologies (Arlington, Virginia, May 9-10, 1985). Washington, DC: Department of the Treasury, Internal Revenue Service, Statistics of Income Division, 1995, publication no. 1299 (2-86).
17. Harrell FE Jr., Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med 1984;3: 143-52.
18. Pryor DB, Harrell FE Jr., Rankin JS, et al. The changing survival benefits of coronary revascularization over time. Circulation 1987;76 Suppl V:V-13-21.
19. Smith LR, Harrell FE Jr., Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991;84 Suppl III:III-245-53.
20. Califf RM, McKinnis RA, Burks J, et al. Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. Am J Cardiol 1982;50:23-31.
21. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634-8.
22. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
23. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992;70:359-63.
24. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993;126:632-40.
25. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
26. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
27. Cohn JN, Johnson GR, Shabetai R, et al., for the V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87 Suppl V:V-15-6.
28. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 1987;75 Suppl IV:IV-11-9.
29. Johnson G, Carson P, Francis GS, Cohn JN, for the V-HeFT VA Cooperative Studies Group. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril: Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). Circulation 1993;87 Suppl V:V-I32-9.
30. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction: the role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 1994;15:1089-95.
31. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.